Replies to post #655 on GTC Biotherapeutics (fka GTCB)

[jessellivermore]

Back to AT111

The really interesting thing IMHO about this AT111 study is the effect on reperperfusion. This could translate to a whole new set of markets for Atryn both in the transplant field and possibly CVAs and AMIs.